Form 4 for CYTK CYTOKINETICS INC
Accepted 2025-12-08 00:00:00 ET · period of report 2025-12-08 · accession 0001061983-25-000049 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-08 | 2025-12-08 | CYTK | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $65.96 | -1,042 | 50.7K | -2% | -$68.7K |
| D | 2025-12-08 | 2025-12-08 | CYTK | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $39.13 | +1,042 | 51.7K | +2% | +$40.8K |
| D | 2025-12-08 | 2025-12-08 | CYTK | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $0.00 | -1,042 | 35.4K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-08 | S | D | 1,042 | $65.96 | 50,660 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-08 | M | A | 1,042 | $39.13 | 51,702 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2025-12-08 | M | D | 1,042 | $0.00 | 35,403 | D | $39.13 · 2023-04-06 to 2033-03-06 | 1,042 Common Stock |